ABSTRACT Background: A large number of potential obesity loci have been reported. At least 18 genes have been replicated in a minimum of 5 studies on obesity-related phenotypes. Fourteen additional genes have been associated with obesity in Asians. Objectives: Our objectives were to examine how many common variants of these candidate genes are associated with severe obesity in Han Chinese and how they are combined to exert their effects. Design: In total, 304 severely obese patients [body mass index (BMI; in kg/m 2 ) 39] and 304 control subjects (BMI 24) participated in a 2-staged association study. Subsequently, 220 additional severely obese patients (BMI 35) and 338 controls (BMI 24) were recruited to replicate the results. All of the controls were age-, sex-, education-and residence-matched. Finally, a pooled analysis was carried out based on all 514 cases and 606 controls with complete information. Results: The first-stage association analysis in 94 cases and 94 controls found 18 potentially associated single nucleotide polymorphisms (SNPs) (P = 0.01-0.1). The significance of 3 novel common SNPs, 1 on ESR1 and 2 on PPARc, were confirmed in the second stage and replicated further with odds ratios ranging from 1.89 to 2.24. The combined effect of these 3 genes was stronger (odds ratio: 5.27; 95% CI: 2.25, 12.32) than that from any individual gene. Conclusions: Severe obesity in Han Chinese was associated with 3 novel common SNPs for ESR1 and PPARc. These 2 genes collectively result in a .5-fold risk of severe obesity. This information may contribute to the assessment of risk of severe obesity.
INTRODUCTION
Obesity is of public health importance because of its adverse effects on health (1, 2) . Considering the prevailing obesogenic environment, it is timely to identify genes that may confer a risk of obesity.
In the latest version of the human obesity gene map, the 127 candidate genes associated with obesity-related phenotypes had been documented in 426 positive findings (3) . Of these genes, the current research focuses on a panel of 18 genes that have been supported by 5 positive studies. Of these 18 genes, PPARc encodes a nuclear receptor involved in adipocyte differentiation and acting as a lipid sensor participating in the regulation of energy storage and glucose and lipid homeostasis (4) (5) (6) . LDLR is a receptor contributing to the regulation of intracellular cholesterol metabolism and adipose tissue accretion (7, 8) . INS, LEP, LEPR, and MC4R have been implicated in the orexigenic/ anorexigenic signaling pathways of energy balance regulation (9) . Mutations in NR3C1 have been associated with obesity, possibly through glucocorticoid resistance and altered hypothalamic-pituitary-adrenal (HPA) axis functions (10, 11) . ADRBs and GNBs participate in the regulation of adenylate cyclase and lipolysis (5, 12, 13) . The UCPs act on reduction of ATP formation, thereby releasing chemical energy as heat (14) . IL6 and TNF-a genes are implicated in glucose and lipid metabolism, especially in immune responses (15) (16) (17) (18) (19) (20) . Of these highly replicated obese candidate genes, ADRBs, GNBs, LEP, MC4R, PPARc, TNF-a, and UCPs are associated with obesity in the Chinese (3, 21, 22) . Additionally, 13 genes have been implicated in Asian obesity (3, 21, 22 ) (Appendix A). Recently, a novel FTO gene (gene ID: 79068) with unknown function has been associated with obesity-related phenotypes in various populations (3, 23, 24) .
Previous studies have suggested that there is considerable heterogeneity on putative obesity loci within a population, but even more so across populations (3). Yet, there have been relatively few comprehensive studies of obesity genes in Chinese or Asian populations. Focusing on the multiple frequently replicated genes and a number of ethnic-specific candidates, we proposed to use a 2-stage association study and a subsequent replication study to search and to confirm the genes associated with the severe obesity of Han Chinese [body mass index (BMI; in kg/m 2 ) 35], a relatively rare phenotype ('0.56% in Taiwan) (25) .
SUBJECTS AND METHODS
Severely obese subjects were selected from those who underwent laparoscopic bariatric surgery in Min-Sheng General Hospital, Taoyuan, Taiwan. The inclusion criteria for the obese subjects were as follows: 1) age 20-55 y, 2) BMI 35, and 3) Han Chinese ancestry of both parents. Of all the recruits, 304 severely obese cases (BMI 39) were included in a 2-staged association study. Subsequently, another 220 severely obese cases (BMI 35) were recruited into a replication study. The study protocol and informed consent form were approved by the institutional review board of the Min-Sheng General Hospital in 2003. All cases were recruited from 2003 to 2006. Signed informed consent was obtained from every subject. Fasting blood specimens were drawn, and clinical biochemistry profiles were assessed.
The nonobese controls (BMI 24), 304 in the second-staged study and 338 in the replication study, were selected from the Taiwan Han Chinese cell and genome bank database, which was completely established before the year 2006 (26) . All controls were matched with cases for sex, age, education level, and residential location.
Study design
With regard to the second-stage design, in the first stage we randomly selected 94 cases and 94 matched controls from the 304 cases and 304 controls and carried out genotyping for 142 single nucleotide polymorphisms (SNPs) in 32 obesity candidate genes (18 genes replicated in 5 previous studies, 13 additional genes, and FTO gene related to obesity in Asians), as shown in Appendix A. In the second stage, the other 210 cases and 210 matched controls were genotyped for those SNPs potentially associated with severe obesity (P 0.1) in the first stage.
We used a conservative P value to avoid losing important SNPs. In addition to the second-stage confirmation, we also designed another replication study to minimize false-positive results. The replication study included 220 cases and 338 matched controls with a control-case ratio of 1.5. Finally, a pooled analysis was carried out based on all 514 cases and 606 controls with complete genotype information to understand the combined effects of multiple influential genes.
SNP selection
The SNPs were selected via the following principles: 1) We included SNPs that were significantly associated with obesity in previous publications. 2) For non-SNP types of genetic markers significantly associated with obesity, SNPs in close proximity or in linkage disequilibrium (LD) were selected. 3) To ensure reasonable coverage of a gene, 1 or 2 tag SNPs were genotyped in each LD block (depending on the length of the LD block) as defined in the CHB (Han Chinese in Beijing) or the JPT (Japanese in Tokyo) database of HapMap (http://www.hapmap.org/). 4) If there were no clear LD blocks in a gene, one SNP was selected for every 3-kb DNA sequence of the gene.
DNA extraction and genotyping
Genomic DNA was extracted from cells of buffy coats by the phenol-chloroform method. The quality of the DNA was assessed by the ratio of the 260-nm to the 280-nm readings obtained from a spectrophotometer. DNA samples were diluted to 2.3-3 ng/lL before sending them to the National Genotyping center in Taiwan, where the PCR products were genotyped with the Multiplexed Homogeneous MassEXTEND (hME) Assay (SEQUENOM, San Diego, CA).
Statistical analyses SAS 9.1.3 software (SAS Institute Inc, Cary, NC) was used for the statistical analysis. Chi-square and t tests were used to compare characteristics of the obese and the nonobese. The associations between candidate genes and obesity were tested by conditional logistic regression, and the P values were calculated based on 10,000 random permutations. The combination effect of influential candidate genes on severe obesity was also tested by a conditional multivariate logistic regression. Mean BMI values between various genotype groups were compared by Tukey's honestly significant difference test.
RESULTS
A comparison of characteristics between the cases and controls during the first-stage, second-stage, and replication studies is shown in Table 1 . BMI, waist circumference, systolic blood pressure, diastolic blood pressure, and fasting serum cholesterol, HDL cholesterol, and uric acid concentration were statistically different between cases and controls at all 3 stages. However, the characteristics of the cases were similar across different stages.
The results of the first-stage association analyses showed that 18 SNPs were potentially associated with severe obesity (P = 0.01-0.1). These 18 SNPs were genotyped in the second stage on an additional set of 210 cases (BMI 39) and 210 controls (BMI 24). Detailed statistical results about the 18 SNPs of the 9 genes in the second-stage study were provided in Appendix B.
In the second-stage study, allelic distribution showed that 4 SNPs flanking 3 genes (ESR1, PPARc, and UCP2) were significantly associated with severe obesity (P = 0.011-0.047) ( Table 2 ). The allelic distributions of 3 SNPs (rs712221, rs1822825, and rs4684846) between cases and controls presented similar trends both in the first-stage and second-stage studies. However, for the rs660339 of UCP2 gene, a lower frequency was observed in the cases for T allele in the first stage, but a higher frequency was observed in the second-stage study. In the subsequent replication study, the significant association between each of the 3 SNPs (rs712221, rs1822825, and rs4684846) and severe obesity was also observed (P = 0.011-0.036), but no significant association with severe obesity was observed for rs660339 of the UCP2 gene ( Table 2) .
The pooled analysis ( Table 3 ) was carried out for the 3 SNPs significantly associated with severe obesity (P , 0.05), both in the second-stage study and the replication study. An additive effect was observed for rs4684846 of PPARc. Individuals with one G allele had a 50% elevation in severe obesity risk and those with a GG genotype had a 101% elevation. The rs1822825 in PPARc and the rs712221 in ESR1 followed a recessive inheritance model, individuals with homogeneous risk alleles had a 124% and 89% increase in obesity risk, respectively. However, heterogeneous individuals did not have any increased risk. The percentage of individuals carrying the risk genotypes at rs712221 (ESR1), rs1822825 (PPARc), and rs4684846 (PPARc) were 25.2%, 21.8%, and 79.9% in the severe obese group and 18.4%, 14.8%, and 72.6% in the control group, respectively ( Table 3) . The multivariate analysis was performed for the above 3 SNPs, with adjustment for the other 2 SNPs. The effect size in terms of odds ratios decreased slightly for each of the 3 SNPs. However, the 3 SNPs (rs712221 of ESR1 and rs4684846 and rs1822825 of PPARc) remained statistically significant.
Furthermore, we examined the effects of the combined genotypes ( Table 4) . Of the 1166 subjects (524 cases and 642 controls), complete genotype data for the 3 SNPs were available for 1120 (96.1%) subjects. The genotype data from these 1120 subjects were used to divide all subjects into 6 subgroups, depending on the risk genotypes they carried. One of the subgroups included the subjects without any risk allele at any of the obesity candidate genes-the nonrisk genotype (NRG). All subgroups were tested in a multivariate conditional logistic regression model with the subgroup of NRG as the reference group. Subjects carrying the ESR1 risk genotype alone or carrying the PPARc risk genotype at one locus only was not associated with a significantly elevated risk of severe obesity (Table 4) . Subjects simultaneously carrying one PPARc risk genotype and the ESR1 risk genotype or carrying risk genotypes on both PPARc loci had a higher risk (odds ratio: 1.92-2.04) of severe obesity than did those carrying only one risk genotype. Furthermore, individuals concurrently carrying the risk genotypes at ESR1 and at both loci of PPARc exhibited an even higher risk (odds ratio: 5.27; 95% CI: 2.25, 12.32). These persons had a significantly higher mean BMI than did the NRG group. However, differences between other obese groups and the NRG group were not significant. No difference was found in mean BMI values between any nonobese control groups.
DISCUSSION
Our study showed that 3 SNPs in 2 genes (ESR1 and PPARc) were significantly associated with severe obesity, including 2 novel SNPs in PPARc and one novel SNP in ESR1.
Estrogen receptor 1 (ESR1) is a ligand-activated transcription factor composed of several domains. ESR1 knockout mice had adipocyte hyperplasia and hypertrophy in white adipose tissue, which was accompanied by insulin resistance and glucose intolerance (27) . It was shown earlier that one restriction enzyme cleavage site, XbaI in intron 1 of ESR1, may contribute to the development of upper-body obesity in middle aged Japanese women (28) . Another ESR1 restriction enzyme cleavage site (Pvu II, in intron 1) may also affect serum lipid metabolism in Chinese women (27) . Although the association between ESR1 variants and BMI in Chinese populations was not previously observed (27) , such a discrepancy may be explained by differences in study design (family-based) and population characteristics (not limited to obese people). Our study found that rs712221, a tag-SNP representing an LD block of '7 kb in intron 2 of ESR1, was significantly associated with severe obesity in Han Chinese. However, no significant associations were found for the 2 aforementioned variants reported by Okura et al. (28) and Huang et al. (27) , because these 2 restriction enzyme sites are outside of the LD coverage of rs712221, which appears to be a new marker of severely obesity in Han Chinese. PPARc is considered a strong candidate gene for the predisposition to obesity because it participates in the regulation of energy storage and glucose and lipid homeostasis, as suggested by previous studies. PPARc has 6 mRNA isoforms (c1, c2, c3, c4, c2ORF4, and c3ORF4) resulting from different alternative splicings (29) (30) (31) . A nonsynonymous SNP (Pro12Ala) and a 2681C/G polymorphism (in promoter) were associated with body weight and height (32) (33) (34) (35) (36) , and the latter marker interacted with the percentage of energy from dietary fat in its association with obesity (29) . The C1431T polymorphism of PPARc (in exon 6) has also been shown to be associated with higher BMI (37) and increased fat mass (38) . These 3 SNPs, however, were not associated with obesity in our study. Instead, significant associations were found for the first time between severe obesity and 2 common SNPs of PPARc (rs4684846 in promoter and rs1822825 in intron 4) in Han Chinese. The rs4684846 is a tag-SNP representing an '8-kb LD block located in the promoter between exon A1 and exon A2. The 5# and 3# ends of this LD block are near the transcriptional start site of PPARc3 ('5 kb apart) and 2681 C/G polymorphism ('9 kb apart), respectively. Future research is needed to examine whether the association with rs4684846 indicates an association with these 2 sites. The rs1822825 is a tag-SNP of an LD block that covers a genomic region from intron 3 to intron 5, and the stop codon of cORF4 lies within this LD block (exon 4). Additional studies are needed to clarify the roles of these 2 LD blocks. These variants of PPARc were not only associated with severe obesity, but their effects were strengthened when risk alleles at ESR1 were also present. Uncoupling protein 2 (UCP2) is an "uncoupler" of oxidative phosphorylation in the mitochondrial membrane and has a potential role in thermogenesis (14, 39) . It has been shown that a nonsynonymous SNP (rs660339: an amino acid substitution of Val for Ala at codon 55 in exon 4) of UCP2 has an effect on thyroid metabolism, impairing energy balance and resulting in body mass and composition changes (40) . Our present study showed an association with opposite directions between this rs660339 and severe obesity in the first-and second-stage studies, and its association with obesity could not be replicated in a separate study. The UCP2 is an environment-sensitive gene. Its effect on obesity and BMI is usually affected by environmental factors such as diet, exercise training, and infection (39, 40) . The heterogeneous results among studies in the different stages may be caused by varied environmental exposures in these patients and controls. Unfortunately, we did not collect enough information for environmental exposures to adjust for potential confounding.
Our study showed that risk genotypes on ESR1 and PPARc together were associated with an augmented risk of severe obesity. Gene-gene interactions between ESR1 and PPARc have been reported. ESR1 bound to PPRE (PPAR response element) has been shown to functionally interfere with peroxisome proliferator-activated receptor (PPARc) signaling (41) . Because we also observed that a certain proportion of nonobese subjects carried obesity-risk genetic variants (data not shown), we hypothesized that severe obesity may be absent in high-risk people with healthy lifestyles and that an obesogenic environment is required for the development of severe obesity.
The sample size of this study was moderate, particularly in the first stage. Therefore, the power of this study allowed only finding genes with a large effect. A larger sample size may be required to observe the statistical significance for small effect genes that might have been missed by this study.
Our data show that 2 novel SNPs in PPARc and one novel SNP in ESR1 were significantly associated with severe obesity and that the combined effects of these 3 SNPs on 2 genes translate into a much larger effect (5.27-fold) than either gene alone. Our findings may contribute to the risk assessment of severe obesity.
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APPENDIX B
Eighteen single nucleotide polymorphisms (SNPs) of 9 genes associated (P = 0.01-0.1) with morbid obesity in the first-stage analysis 
